首页> 中国专利> 一种治疗闭合性外伤疼痛的散剂药物及其制备方法

一种治疗闭合性外伤疼痛的散剂药物及其制备方法

页面导航

摘要
著录项
法律信息
相似文献

摘要

一种治疗闭合性外伤疼痛的散剂药物及其制备方法，所述药物的各个组分及其质量份比为：田三七、沉香、牛黄、珍珠、麝香、熊胆、血竭、琥珀、硃砂、土鳖、无名异、人中白和冰片各1-3份；该药物的制备方法包括如下步骤：按照质量份比选购优质干净的一级田三七、沉香、牛黄、珍珠、麝香、熊胆、血竭、琥珀、硃砂、土鳖、无名异、人中白、冰片、西红花，分别拣去残余杂质后备用；首先将上述药物用超微细机研磨成粉末状，然后再将粉末状药物放入容器内，进而混合搅拌，待拌均后，过筛即得成品散剂药物，装瓶密封备用即可。

著录项

公开/公告号CN104983981A

专利类型发明专利
公开/公告日2015-10-21

原文格式PDF
申请/专利权人四川金堂海纳生物医药技术研究所;
展开▼

申请/专利号CN201510410894.6
发明设计人夏瑜;
展开▼

申请日2015-07-14
分类号A61K36/889(20060101);A61K36/896(20060101);A61K9/14(20060101);A61P29/00(20060101);A61K35/64(20150101);A61K35/618(20150101);A61K35/55(20150101);A61K35/413(20150101);A61K35/22(20150101);A61K35/10(20150101);A61K33/32(20060101);A61K31/045(20060101);A61K33/28(20060101);
代理机构
代理人
地址 610499 四川省成都市金堂县赵镇新生村三组1幢2楼
入库时间 2023-12-18 11:23:54

法律信息

法律状态公告日

法律状态信息

法律状态
2015-11-18

实质审查的生效 IPC(主分类):A61K36/889 申请日:20150714

实质审查的生效
2015-10-21

公开

公开

相似文献

专利
中文文献
外文文献

1. 一种治疗闭合性外伤疼痛的散剂药物及其制备方法 [P] . 中国专利： CN104983981A . 2015-10-21
2. 一种治疗慢性中重度非外伤性软组织疼痛的药物及其制备方法 [P] . 中国专利： CN108144028A . 2018-06-12
3. compound of formula i; pharmaceutical composition; method of treating disorders that are related to or affected by inhibition of norepinephrine reuptake, the 5-ht6 receptor or the 5-ht2a receptor; a method of treating a learning disorder, a cognitive disorder, a memory disorder, a personality disorder, a behavioral disorder, a movement disorder, a neurodegenerative disorder, drug withdrawal disorder, sleep, an eating disorder, acute drug toxicity, a cardiovascular disorder, a sexual dysfunction, a gastrointestinal disorder, a genitourinary disorder, a pain disorder, a nervous disorder or a symptom disorder vasomotor; method of treating alzheimer's disease, attention deficit disorder, schizophrenia, parkinson's disease, tardive dyskinesia, ataxia, bradykinesia, paroxysmal dyskinesias, restless leg syndrome, tremor, essential tremor epilepsy, stroke or head trauma; method of treating coronary artery disease, myocardial infarction, transient ischemic attack, angina, atrial fibrillation, p [P] . BRPI0706523A2 . 2011-01-04

机译：式I化合物;药物组合物;治疗与去甲肾上腺素再摄取，5-ht6受体或5-ht2a受体相关或受其抑制的疾病的方法;一种治疗学习障碍，认知障碍，记忆障碍，人格障碍，行为障碍，运动障碍，神经退行性疾病，戒断药物，睡眠，进食障碍，急性药物毒性，心血管疾病的方法，性功能障碍，胃肠道疾病，泌尿生殖系统疾病，疼痛疾病，神经疾病或症状-血管舒缩;治疗阿尔茨海默氏病，注意力缺陷障碍，精神分裂症，帕金森氏病，迟发性运动障碍，共济失调，运动迟缓，阵发性运动障碍，不安腿综合征，震颤，原发性震颤癫痫，中风或头部外伤的方法;治疗冠状动脉疾病，心肌梗塞，短暂性脑缺血发作，心绞痛，心房颤动，p的方法
4. compound, pharmaceutical composition; use of the compound for the manufacture of a medicament for treating irritable bowel syndrome, treating pain or painful syndromes, treating urinary incontinence, treating depression, fibromyalgia, anxiety, panic disorder, agorophobia, pre-traumatic stress disorder, pre-dysphoric disorder menstrual disorder, attention deficit disorder, obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, autism, schizophrenia, obesity, anorexia nervosa, bulimia nervosa, gilles de la tourette syndrome, vasomotor discharge, cocaine addiction, sexual dysfunction, personality threshold disorder, fibromyalgia syndrome, diabetic neuropathic pain, chronic fatigue syndrome, shy drager syndrome, raynaud syndrome, parkinson's disease, and epilepsy, method of preparing a compound of structure (a), and Method of preparing a compound of structure (b) [P] . BRPI0613031A2 . 2012-01-03

机译：化合物，药物组合物;该化合物在制备用于治疗肠易激综合症，治疗疼痛或疼痛综合症，治疗尿失禁，治疗抑郁症，纤维肌痛，焦虑症，恐慌症，广场恐惧症，创伤前应激障碍，烦躁不安症，月经失调的药物中的用途，注意力缺陷障碍，强迫症，社交焦虑症，广泛性焦虑症，自闭症，精神分裂症，肥胖症，神经性厌食症，神经性贪食症，抽动秽语综合征，血管舒缩放电，可卡因成瘾，性功能障碍，人格阈障碍，纤维肌痛综合征，糖尿病性神经性疼痛，慢性疲劳综合症，害羞药物综合征，雷诺氏综合症，帕金森氏病和癫痫病，结构式（a）的化合物的制备方法和结构式（b）的化合物的制备方法
5. Compound, use and process for its preparation, pharmaceutical formulation, treatment processes or risk reduction of, a human disease or condition in which the inhibition of nitric oxide synthase activity is beneficial, treatment, or risk reduction, hypoxia, or stroke or ischemia or neurodegenerative conditions, or schizophrenia or pain or migraine, or for the prevention and reversal of tolerance to opiates and diazepines, or for the treatment of drug addiction, treatment, or reducing the risk of suffering from pain, for the treatment of parkinson's disease [P] . BR9808725A . 2000-07-11

机译：抑制一氧化氮合酶活性有益的人类疾病或病症的化合物，其制备方法，用途，制备方法，治疗方法或降低风险，治疗或降低风险，缺氧或中风或局部缺血或神经退行性变疾病，精神分裂症或疼痛或偏头痛，或预防和逆转鸦片和二氮杂tolerance的耐受性，或用于治疗药物成瘾，治疗帕金森氏病或减轻疼痛的风险